Results 61 to 70 of about 7,712 (183)

Comparison of characteristics after 3 months of biological disease-modifying antirheumatic drug (bDMARD) therapy between the patients with high and low anti-Porphyromonas gingivalis peptidylarginine deiminase (PPAD) immunoglobulin G (IgG) titers.

open access: yes, 2016
Comparison of characteristics after 3 months of biological disease-modifying antirheumatic drug (bDMARD) therapy between the patients with high and low anti-Porphyromonas gingivalis peptidylarginine deiminase (PPAD) immunoglobulin G (IgG) titers.
Tetsuo Kobayashi (807280)   +7 more
core   +1 more source

TcpC inhibits neutrophil extracellular trap formation by enhancing ubiquitination mediated degradation of peptidylarginine deiminase 4

open access: yesNature Communications, 2021
TcpC is a well characterised multifunctional virulence factor expressed by uropathogenic Eschericia coli. Here the authors show that TcpC also targets neutrophil NETosis via its E3 ligase functionality promoting the degradation of PAD4, and represents an
Qian Ou   +12 more
doaj   +1 more source

Peptidylarginine deiminase (PAD) 6 is essential for oocyte cytoskeletal sheet formation and female fertility

open access: yes, 2007
Peptidylarginine deiminase 6 (PAD6) is an enzyme that is uniquely expressed in male and female germ cells. To study the function of this enzyme in vivo we generated mice deficient for PAD6. Here we show that inactivation of the PAD6 gene in mice leads to
Vitale, A.M.   +14 more
core   +1 more source

Role of Porphyromonas gingivalis’s peptidylarginine deiminase in multispecies biofilm formation and bacterial adherence to host cells

open access: yesJournal of Oral Microbiology, 2017
Porphyromonas gingivalis’s peptidylarginine deiminase (PPAD) is one of the most unique virulence factors in the pathogenesis of periodontitis, as well as one of the possible links between this chronic inflammatory disease and other disorders, like ...
Ardita Aliko   +5 more
doaj   +1 more source

Porphyromonas gingivalis exacerbates ulcerative colitis via Porphyromonas gingivalis peptidylarginine deiminase

open access: yesInternational Journal of Oral Science, 2021
Ulcerative Colitis (UC) has been reported to be related to Porphyromonas gingivalis (P. gingivalis). Porphyromonas gingivalis peptidylarginine deiminase (PPAD), a virulence factor released by P. gingivalis, is known to induce inflammatory responses.
Xida Zhao   +10 more
doaj   +1 more source

Mast cell extracellular trap formation underlies vascular and neural injury and hyperalgesia in sickle cell disease

open access: yesLife Science Alliance
Mast cell extracellular traps catalyzed by peptidylarginine deiminase 4 contribute to vascular stasis and nerve injury, which may contribute to acute and chronic pain in sickle cell disease.
Donovan A Argueta   +10 more
doaj   +1 more source

Generation and characterisation of Porphyromonas gingivalis mutant lacking peptidylarginine deiminase activity

open access: yesJournal of Oral Microbiology, 2017
Porphyromonas gingivalis peptidylarginine deiminase (PPAD) is the focus of several studies due to its ability to citrullinate in vitro human proteins, which have been linked to the aetiopathogenesis of rheumatoid arthritis (RA).
Estefanía Muñoz-Atienza   +5 more
doaj   +1 more source

Peptidylarginine Deiminase 2 in Murine Antiviral and Autoimmune Antibody Responses

open access: yesJournal of Immunology Research, 2022
The peptidylarginine deiminases (PADs) and the citrullinated proteins that they generate have key roles in innate immunity and rheumatoid arthritis, an inflammatory arthritis with antibodies that target citrullinated proteins.
Aisha M. Mergaert   +7 more
doaj   +1 more source

A continuous spectrophotometric assay method for peptidylarginine deiminase type 4 activity

open access: yes, 2005
A simple, continuous spectrophotometric assay for peptidylarginine deiminase (PAD) is described. Deimination of peptidylarginine results in the formation of peptidylcitrulline and ammonia.
Liao, Y.F.   +8 more
core   +1 more source

Structures of human peptidylarginine deiminase type III provide insights into substrate recognition and inhibitor design

open access: yes, 2021
Peptidylarginine deiminase type III (PAD3) is an isozyme belonging to the PAD enzyme family that converts arginine to citrulline residue(s) within proteins. PAD3 is expressed in most differentiated keratinocytes of the epidermis and hair follicles, while
Kizawa, Kenji   +10 more
core   +1 more source

Home - About - Disclaimer - Privacy